Aberdeen Group
TECX

Aberdeen Group’s Tectonic Therapeutic TECX Stock Holding History

Aberdeen Group’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3M Hold
1,141,824
– – 0.06% 272
2026
Q1 		$35.3M Hold
1,141,824
– – 0.06% 284
2025
Q4 		$23.8M Buy
1,141,824
+785,648
+221% +$14.6M 0.04% 374
2025
Q3 		$5.59M Buy
+356,176
New +$7.35M 0.01% 689

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Aberdeen Group's TECX Position: Q2 2026 in Review

Aberdeen Group held its Tectonic Therapeutic (TECX) position steady in Q2 2026 at 1,141,824 shares worth $39.3M. The position accounts for 0.06% of the portfolio, ranked #272.

Aberdeen Group first reported a position in TECX in Q3 2025 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Aberdeen Group held 1,141,824 shares of Tectonic Therapeutic worth $39.3M as of Q2 2026.
  • Aberdeen Group left its Tectonic Therapeutic share count unchanged in Q2 2026.
  • Tectonic Therapeutic made up 0.06% of Aberdeen Group's portfolio in Q2 2026, its #272 holding.
  • Aberdeen Group first reported a position in Tectonic Therapeutic in Q3 2025 and has held it in 4 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.